Catalyst Wire Dossier Catalyst Wire Dossier

IHEEZO

Chloroprocaine hydrochloride ophthalmic gel · Harrow Eye, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IHEEZO, covering 2022-09-27 to 2022-09-27. Get the full timeline:

Most recent: FDA Approved: IHEEZO — Original Application (Harrow Eye, LLC)

See pricing